estimated revenue glp-1 drugs Market Size, Scope, Forecast Report 2026 to 2035 The winners and losers from

Traditionally, T2DM has been described by the triumvirate: 1) impaired insulin secretion due to declining pancreatic -cell function

The result indicate that liraglutide could significantly improve BMD, bone microstructure, bone biomechanical markers, ALP, OC and decrease TRACP and serum c-terminal telopeptide of type 1 collagen (CTX-I), compared with the dexamethasone group

2 The American Diabetes Association 2016 guideline details a number of second-line options for use following MET and does not give preference to one drug class over the other

J Clin Endocrinol Metab 37(5):826828 Elahi D, Andersen DK, Brown JC et al (1979) Pancreatic alpha-and beta-cell responses to GIP infusion in normal man

R.et al (2018)